Related news from
Thu, 02 Apr 2026 14:00:20 +0000	2 S&P 500 Stocks with Exciting Potential and 1 We Ignore The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
Wed, 01 Apr 2026 20:30:00 +0000	Cencora Announces Date and Time for Second Quarter Fiscal 2026 Earnings Release CONSHOHOCKEN, Pa., April 01, 2026--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Second Quarter of Fiscal 2026 on Wednesday, May 6, 2026, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on May 6, 2026.
Wed, 01 Apr 2026 14:27:00 +0000	Can CAH's Specialty Flywheel Strategy Unlock Long-Term Growth? CAH's specialty flywheel strategy links distribution, MSOs and biopharma services, boosting partnerships, drug launches and recurring revenue potential.
Tue, 31 Mar 2026 10:21:19 +0000	1 Large-Cap Stock for Long-Term Investors and 2 We Avoid Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.
Tue, 31 Mar 2026 05:03:35 +0000	Is It Time To Reassess Cencora (COR) After The Recent Share Price Pullback? Investors may be wondering whether Cencora is attractively priced after its recent run and pullback, or if the stock is now reflecting too much optimism. The share price closed at US$309.93, with a 3.3% decline over the last 7 days and a 16.7% decline over the last 30 days. This is set against a 12.2% return over 1 year and very strong returns over 3 and 5 years. Recent coverage has focused on Cencora as a key healthcare distributor and supply chain player, with attention on how it fits into...
Mon, 30 Mar 2026 11:39:57 +0000	Cencora, Inc. (COR) Signs Binding Agreement to Expand Retina Network With EyeSouth Acquisition We recently compiled a list of the 13 Best Stocks to Invest In on Robinhood for Beginners. Cencora, Inc. is the next best Robinhood stock on this list. TheFly reported on March 23 that COR revealed that it has signed a binding agreement to acquire the retina division of EyeSouth Partners for $1.1 billion. Once the […]
Thu, 26 Mar 2026 14:57:21 +0000	Reflecting On Health Insurance Providers Stocks’ Q4 Earnings: Cencora (NYSE:COR) As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at health insurance providers stocks, starting with Cencora (NYSE:COR).
Wed, 25 Mar 2026 02:34:22 +0000	Why STAAR Surgical (STAA) Stock Is Trading Up Today Shares of medical lens company STAAR Surgical (NASDAQ:STAA) jumped 3.7% in the afternoon session after investors reacted to positive news in the broader ophthalmology sector as Cencora agreed to acquire EyeSouth Partners' retina business for $1.1 billion.
Tue, 24 Mar 2026 14:21:00 +0000	COR to Expand Retina Consultants of America With $1.1B EyeSouth Deal Cencora is acquiring EyeSouth's retina business for $1.1 billion, expanding its RCA platform to strengthen foothold in the fast-growing eye care market.
Tue, 24 Mar 2026 12:15:00 +0000	Kultura Brands (OTC:LTNC) Accelerates National Momentum With Cencora Marketplace Spring & Summer Growth Acceleration Program JACKSON, WY / ACCESS Newswire / March 24, 2026 / Kultura Brands Inc., formerly known as Labor Smart INC. (OTCID:LTNC), a rapidly emerging platform focused on high-growth beverage and functional wellness brands, today announced its expanded participation ...
Tue, 24 Mar 2026 09:19:42 +0000	Cencora to buy EyeSouth’s retina business for $1.1B The proposed acquisition is Cencora’s latest push into retina services as the company looks to expand its specialty support business. Cencora doesn't expect the deal to close before the end of September.
Mon, 23 Mar 2026 20:47:11 +0000	Wall Street Snaps 3-Day Losing Streak, Oil Retreats as Trump Postpones Strikes on Iran US equities rallied Monday after three straight sessions of losses, while oil prices slid as Preside
Mon, 23 Mar 2026 19:54:59 +0000	Sector Update: Health Care Stocks Advance Late Afternoon Health care stocks rose late Monday afternoon with the NYSE Health Care Index up 0.5% and the State
Mon, 23 Mar 2026 18:13:45 +0000	Equities Rise Intraday, Oil Plunges as Trump Delays Strikes on Iranian Energy Infrastructure US benchmark equity indexes were higher intraday, while oil prices tumbled after President Donald Tr
Mon, 23 Mar 2026 17:14:29 +0000	US Equity Indexes Jump, Crude Oil Slides as Trump Offers 5-Day Reprieve to Iran Amid 'Productive' Talks US equity indexes jumped in midday trading Monday as President Donald Trump's move to postpone a pla
Mon, 23 Mar 2026 16:04:00 +0000	Active ETFs Surge Past Passive, and These Are in the Lead Actively managed ETFs have become increasingly popular among investors willing to pay a premium for flexibility, star managers, and sophisticated strategies.
Mon, 23 Mar 2026 13:39:11 +0000	Cencora to Acquire EyeSouth Partners' Retina Business in $1.1 Billion Deal Cencora (COR) said Monday that it will acquire EyeSouth Partners' retina business for $1.1 billion a
Mon, 23 Mar 2026 11:00:00 +0000	Cencora to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners’ Retina Business CONSHOHOCKEN, Pa., March 23, 2026--Cencora, Inc. (NYSE: COR) today announced the signing of a definitive agreement to acquire EyeSouth Partners’ retina business for $1.1 billion. Upon completion of the transaction, the affiliated retina physicians of EyeSouth Partners will join Cencora’s Retina Consultants of America ("RCA"), a leading management services organization (MSO).
Sun, 22 Mar 2026 16:05:06 +0000	Cencora CFO Retirement Puts Capital Allocation And Growth Plans In Focus Cencora (NYSE:COR) announced the planned retirement of Chief Financial Officer and Executive Vice President James F. Cleary. The company has begun a leadership transition process and initiated an executive search to identify his successor. Cleary’s retirement marks the end of a long tenure in the CFO role and a significant change in Cencora’s senior leadership team. Cencora, a major player in pharmaceutical distribution and related services, sits at the center of global drug supply chains,...
Fri, 20 Mar 2026 13:25:05 +0000	Here’s Why Cencora (COR) Shares Rose 8% in Q4 TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The strategy returned -3.55% (gross) and -3.76% (net) in the fourth quarter compared to a -3.70% return for the Russell Midcap Growth Index. In 2025, the strategy returned 14.84% […]

If you are already a Value Forum member but are not logged on, click here to log on. If you are a guest, thank you for visiting ValueForum -- click here for information about guest access or click here to join -- a Trial Pass can be purchased for $6.99 to help you decide if you want to commit to longer term membership. Did you know there are customized portals into VF like REITs.ValueForum.com and also My ValueForum which lets you customize your VF experience to the posters and topics that most interest you!